“ Switzerland's life sciences heritage creates natural synergies across biotech, pharmaceutical, and medtech sectors. ”
In Conversation
“ In CGT, the line between innovator and CDMO is blurred. We invest significantly in internal R&D and process development capabilities, ensuring we remain at the forefront… ”
“ We are committed to being here for the long haul, anticipating and managing complex challenges, and continuously identifying opportunities that create value for both patients and… ”
“ Sleep disorders are real, and they deserve attention not just from a clinical standpoint, but also from a public health and ethical perspective. ”
“ We invest in people and in outcomes, but always with the purpose of improving patients’ lives. ”
“ We are working very actively to make sure that the new medications coming out of our pipeline every year can really make it to patients. ”
“ Hearing key opinion leaders say, ‘LEO is back,’ reinforces that we are becoming more agile, curious, and forward-looking. ”
“ We have a longstanding tradition of public-private collaboration grounded in trust, transparency, and openness. These cultural elements create an environment where science, and clinical trials in… ”
“ Healthcare is a domain where digital tools can truly make a difference, improving systems and the quality of care. ”
“ IBSA core strengths are entrepreneurship and innovation and our president and founder is an example about it. ”
“ Drug assets are not like wine, they need to be in the right hands to realise their full potential. ”
“ We invest in technologies that we believe will shape the future, and we see them realised through instruments that support both fundamental discovery and real-world application. ”
